Inorganic nanosystems for therapeutic delivery: status and prospects.

Inorganic nanomaterials have an array of structural and physical properties that can be used in therapeutic delivery systems. The sizes, shapes, and surfaces of inorganic nanomaterials can be tailored to produce distinct interactions with biological systems both in vitro and in vivo. Nanoparticle cores can likewise be engineered to possess unique opticophysical properties, including upconversion, size-dependent absorbance/emission as well as magnetic properties such as superparamagnetism. These properties make inorganic nanomaterials as useful imaging agents for noninvasive diagnostics and remotely activated theragnostics. Taken together, these unique properties of inorganic nanomaterials make them promising delivery systems.

[1]  Taeghwan Hyeon,et al.  Inorganic Nanoparticles for MRI Contrast Agents , 2009 .

[2]  Stanislav Emelianov,et al.  Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. , 2009, Nano letters.

[3]  B. Liedberg,et al.  Polypeptide folding-mediated tuning of the optical and structural properties of gold nanoparticle assemblies. , 2011, Nano letters.

[4]  Brahim Lounis,et al.  Direct investigation of intracellular presence of gold nanoparticles via photothermal heterodyne imaging. , 2011, ACS nano.

[5]  Fan Zhang,et al.  Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. , 2012, Nano letters.

[6]  Dai Fukumura,et al.  A nanoparticle size series for in vivo fluorescence imaging. , 2010, Angewandte Chemie.

[7]  Indrajit Roy,et al.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. , 2010, ACS nano.

[8]  S. Nie,et al.  A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. , 2010, ACS nano.

[9]  Warren C W Chan,et al.  Effect of gold nanoparticle aggregation on cell uptake and toxicity. , 2011, ACS nano.

[10]  J. Cheon,et al.  Theranostic magnetic nanoparticles. , 2011, Accounts of chemical research.

[11]  Baowei Fei,et al.  Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. , 2008, Journal of the American Chemical Society.

[12]  Jinwoo Cheon,et al.  All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. , 2009, Angewandte Chemie.

[13]  Laurence Raehm,et al.  Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. , 2012, International journal of pharmaceutics.

[14]  Chad A Mirkin,et al.  Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates. , 2011, ACS nano.

[15]  Mostafa A. El-Sayed,et al.  Beating cancer in multiple ways using nanogold. , 2011, Chemical Society reviews.

[16]  Yong Zhang,et al.  Small upconverting fluorescent nanoparticles for biomedical applications. , 2010, Small.

[17]  Brian P. Timko,et al.  Remotely Triggerable Drug Delivery Systems , 2010, Advanced materials.

[18]  Michael J Sailor,et al.  Cooperative Nanoparticles for Tumor Detection and Photothermally Triggered Drug Delivery , 2009, Advanced materials.

[19]  Wei Feng,et al.  Blue-emissive upconversion nanoparticles for low-power-excited bioimaging in vivo. , 2012, Journal of the American Chemical Society.

[20]  Michael J Sailor,et al.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.

[21]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[22]  Younan Xia,et al.  Inorganic nanoparticle-based contrast agents for molecular imaging. , 2010, Trends in molecular medicine.

[23]  Sanjib Bhattacharyya,et al.  Inorganic Nanoparticles in Cancer Therapy , 2011, Pharmaceutical Research.

[24]  Sarit S. Agasti,et al.  Recognition-Mediated Activation of Therapeutic Gold Nanoparticles Inside Living Cells , 2010, Nature chemistry.

[25]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[26]  M. E. Kenney,et al.  Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? , 2011, Small.

[27]  V. Rotello,et al.  Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. , 2009, Journal of the American Chemical Society.

[28]  Chenjie Xu,et al.  Porous hollow Fe(3)O(4) nanoparticles for targeted delivery and controlled release of cisplatin. , 2009, Journal of the American Chemical Society.

[29]  Vincent M Rotello,et al.  Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.

[30]  M. Galli,et al.  Quantum confinement and electroluminescence in ultrathin silicon nanowires fabricated by a maskless etching technique , 2012, Nanotechnology.

[31]  Vincent M Rotello,et al.  Photoregulated release of caged anticancer drugs from gold nanoparticles. , 2009, Journal of the American Chemical Society.

[32]  Mauro Ferrari,et al.  Nanotechnology and tumor imaging: seizing an opportunity. , 2004, Molecular imaging.

[33]  Shan Jiang,et al.  Multicolor Core/Shell‐Structured Upconversion Fluorescent Nanoparticles , 2008 .

[34]  Shuming Nie,et al.  Bioconjugated quantum dots for in vivo molecular and cellular imaging. , 2008, Advanced drug delivery reviews.

[35]  Younan Xia,et al.  The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. , 2011, Nature nanotechnology.

[36]  Jesse V Jokerst,et al.  Molecular imaging with theranostic nanoparticles. , 2011, Accounts of chemical research.

[37]  Warren C W Chan,et al.  Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.

[38]  Molly M Stevens,et al.  Enzyme-responsive nanoparticles for drug release and diagnostics. , 2012, Advanced drug delivery reviews.

[39]  E. Zubarev,et al.  Paclitaxel-functionalized gold nanoparticles. , 2007, Journal of the American Chemical Society.

[40]  Jerry S. H. Lee,et al.  Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.

[41]  C. Kumar,et al.  Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. , 2011, Advanced drug delivery reviews.

[42]  Clemens Burda,et al.  The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. , 2012, Chemical Society reviews.

[43]  V. Rotello,et al.  Multiplexed screening of cellular uptake of gold nanoparticles using laser desorption/ionization mass spectrometry. , 2008, Journal of the American Chemical Society.

[44]  W. Freeman,et al.  Porous silicon in drug delivery devices and materials. , 2008, Advanced drug delivery reviews.

[45]  J. Fraser Stoddart,et al.  Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. , 2010, Journal of the American Chemical Society.

[46]  Jin Xie,et al.  Nanoparticle-based theranostic agents. , 2010, Advanced drug delivery reviews.